GSK plc

Common Name

GSK

Country

United Kingdom

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

68,629

Ticker

GSK

Exchange

LONDON STOCK EXCHANGE

Website

www.gsk.com

Description

GSK plc is a leading global healthcare company that researches, develops, and manufactures innovative pharmaceutical and consumer healthcare products. This company primarily focuses on creating vaccin... Show more

Financial Statements of GSK

Below are the financial statements of GSK, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of GBP	2024	2023	2022
Turnover	31,376^a	30,328^a	29,324^a
Cost of sales	-9,048^a	-8,565^a	-9,554^a
Gross profit	22,328^a	21,763^a	19,770^a
Selling, general and administration	-11,015^a	-9,385^a	-8,372^a
Research and development	-6,401^a	-6,223^a	-5,488^a
Royalty income	639^a	953^a	758^a
Other operating income/(expense)	-1,530^a	-363^a	-235^a
Operating profit	4,021^a	6,745^a	6,433^a
Finance income	122^a	115^a	76^a
Finance expense	-669^a	-792^a	-879^a
Share of after tax profit/(loss) of associates and joint ventures	-3^a	-5^a	-2^a
Profit/(loss) on disposal of interests in associates and joint ventures	6^a	1^a	0^a
Profit before taxation	3,477^a	6,064^a	5,628^a
Taxation	-526^a	-756^a	-707^a
Profit after taxation from continuing operations	2,951^a	5,308^a	4,921^a
Profit after taxation from discontinued operations and other gains/(losses) from the demerger	0^a	0^a	3,049^a
Re-measurement of discontinued operations distributed to shareholders on demerger	0^a	0^a	7,651^a
Profit after taxation from discontinued operations	0^a	0^a	10,700^a
Total profit after taxation for the year	2,951^a	5,308^a	15,621^a
Profit attributable to non-controlling interests from continuing operations	376^a	380^a	460^a
Profit attributable to shareholders from continuing operations	2,575^a	4,928^a	4,461^a
Profit attributable to non-controlling interests from discontinued operations	0^a	0^a	205^a
Profit attributable to shareholders from discontinued operations	0^a	0^a	10,495^a
Total profit attributable to non-controlling interests	376^a	380^a	665^a
Total profit attributable to shareholders	2,575^a	4,928^a	14,956^a

Verified Sources Behind GSK’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore GSK’s data sources below and access millions more through our Disclosure Search.

a. GSK's Annual Report 2024

Trace every data point back to GSK’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

GSK plc

Financial Statements of GSK

Verified Sources Behind GSK’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

AstraZeneca PLC

Verona Pharma PLC

LivaNova PLC

Smith & Nephew PLC

Haleon PLC

ConvaTec Group PLC